Hyaluronic acid gel spacer study for cervical cancer radiation
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests if a gel spacer made from hyaluronic acid can protect healthy tissue during radiation for cervical cancer. It may help reduce side effects for patients getting chemoradiotherapy with brachytherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have cervical cancer confirmed by biopsy or cell sample.
- You are planning to receive chemoradiotherapy with brachytherapy (internal radiation).
- You must not have rectal invasion from the cancer.
- You cannot be pregnant or breastfeeding.
- You must not have an active infection needing IV antibiotics, allergies to hyaluronic acid, or inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a gel placed in the rectum during radiation therapy to protect healthy tissue after prostate removal. It is for men whose prostate cancer has come back (PSA rise) and who need radiation to the prostate bed.
This trial studies whether placing a soft gel spacer near the rectum can make “salvage” prostate radiation safer and more tolerable when prostate cancer comes back locally. It may help reduce side effects by creating extra space between the rectum and the radiation area.
This study tests whether putting hyaluronic acid (a natural substance) directly into the bladder can help prevent radiation cystitis (bladder inflammation and pain from radiation) in people receiving radiation and chemotherapy for muscle-invasive bladder cancer. If it works, it may help you tolerate treatment better and keep your bladder healthy.
This study tests a vaginal gel to promote vaginal health after radiation therapy for gynecologic cancer. If you've finished pelvic radiation, this gel may help with healing and comfort.
This trial compares two types of radiation boost therapy for locally advanced cervical cancer: a newer, precise type called SABR versus the standard brachytherapy. The goal is to see if SABR works as well or better with fewer side effects.
This trial studies how the immune system responds to pelvic radiation therapy (with or without chemotherapy) in patients with cervical or other gynecologic cancers. It may help explain why some treatments work better and could lead to better treatments in the future.
Hear when a new Cervix Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.